Histopathological characterization of ductal carcinoma in situ (DCIS) of the breast according to HER2 amplification status and molecular subtype-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Histopathological characterization of ductal carcinoma in situ (DCIS) of the breast according to HER2 amplification status and molecular subtype

Published:2014-06-29 Issue:3 Volume:465 Page:275-289
ISSN:0945-6317
Container-title:Virchows Archiv
language:en
Short-container-title:Virchows Arch

Author:

Van Bockstal Mieke,Lambein Kathleen,Denys Hannelore,Braems Geert,Nuyts Ann,Van den Broecke Rudy,Cocquyt Veronique,De Wever Olivier,Libbrecht Louis

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology,General Medicine,Pathology and Forensic Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00428-014-1609-3.pdf

Reference48 articles.

1. Allred DC, Clark GM, Molina R, Tandon AK, Schnitt SJ, Gilchrist KW, Osborne CK, Tormey DC, McGuire WL (1992) Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer. Hum Pathol 23:974–979

2. Altintas S, Lambein K, Huizing MT, Braems G, Tjin Asjoe F, Hellemans H, Van Marck E, Weyler J, Praet M, Van den Broecke R, Vermorken JB, Tjalma WA (2009) Prognostic significance of oncogenic markers in ductal carcinoma in situ of the breast: a clinicopathologic study. Breast J 15:120–132

3. Barnes DM, Bartkova J, Camplejohn RS, Gullick WJ, Smith PJ, Millis RR (1992) Overexpression of the c-erbB-2 oncoprotein: why does this occur more frequently in ductal carcinoma in situ than in invasive mammary carcinoma and is this of prognostic significance? Eur J Cancer 28:644–648

4. Bijker N, Donker M, Wesseling J, den Heeten GJ, Rutgers EJ (2013) Is DCIS breast cancer, and how do I treat it? Curr Treat Options Oncol 14:75–87. doi: 10.1007/s11864-012-0217-1

5. Burkhardt L, Grob TJ, Hermann I, Burandt E, Choschzick M, Janicke F, Muller V, Bokemeyer C, Simon R, Sauter G, Wilczak W, Lebeau A (2010) Gene amplification in ductal carcinoma in situ of the breast. Breast Cancer Res Treat 123:757–765. doi: 10.1007/s10549-009-0675-8

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic assessment of HER2 status in ductal carcinoma in situ of the breast: a perspective on the potential clinical relevance;Breast Cancer Research;2024-08-27

2. Progression from ductal carcinoma in situ to invasive breast cancer: molecular features and clinical significance;Signal Transduction and Targeted Therapy;2024-04-03

3. Correlation of Sonographic Features with Prognostic Factors in Ductal Carcinoma In Situ: An Exploratory Study Using Ultrasound and Shear Wave Elastography;2023-12-13

4. Learning to distinguish progressive and non-progressive ductal carcinoma in situ;Nature Reviews Cancer;2022-10-19

5. Molecular subtyping reveals uniqueness of prognosis in breast ductal carcinoma in situ patients with lumpectomy;The Breast;2022-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3